2020
Musculoskeletal Pain Symptoms and Injuries Among Endoscopists Who Perform ERCP
Campbell EV, Muniraj T, Aslanian HR, Laine L, Jamidar P. Musculoskeletal Pain Symptoms and Injuries Among Endoscopists Who Perform ERCP. Digestive Diseases And Sciences 2020, 66: 56-62. PMID: 32144599, DOI: 10.1007/s10620-020-06163-z.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyMusculoskeletal pain symptomsPain symptomsRisk factorsMusculoskeletal injuriesPrevalent musculoskeletal injuriesDe Quervain's tenosynovitisPotential risk factorsRisk of injuryAnonymous electronic surveyNeck painBack painQuervain's tenosynovitisRetrograde cholangiopancreatographyResultsA totalPreventative strategiesConclusionsThe majorityInjurySymptomsEndoscopistsProtective gearMultiple studiesHalf reportTenosynovitisElectronic survey
2019
Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review
Johnson KD, Perisetti A, Tharian B, Thandassery R, Jamidar P, Goyal H, Inamdar S. Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review. Digestive Diseases And Sciences 2019, 65: 361-375. PMID: 31792671, DOI: 10.1007/s10620-019-05970-3.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalCholangiopancreatography, Endoscopic RetrogradeCholangitisCholecystitisDisinfectionDuodenoscopesEquipment ContaminationHumansInfectionsIntestinal PerforationPancreatic DuctsPancreatitisPatient SelectionPostoperative ComplicationsPostoperative HemorrhageRisk FactorsStents
2018
Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2018, 47: 1142-1149. PMID: 30134357, DOI: 10.1097/mpa.0000000000001143.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisIncidence risk ratioCholangiopancreatography pancreatitisCannabis useRisk of PEPEndoscopic retrograde cholangiopancreatography pancreatitisUS Nationwide Inpatient SampleRate of PEPShorter hospital stayNationwide Inpatient SampleNinth Edition codesImpact of cannabisPoisson regression modelsHospital deathHospital stayIndependent predictorsEdition codesRisk ratioInpatient SampleInternational ClassificationMultivariate analysisPancreatitisPatientsCannabisSignificant increase
2015
Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview
Rustagi T, Jamidar PA. Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview. Gastrointestinal Endoscopy Clinics Of North America 2015, 25: 97-106. PMID: 25442961, DOI: 10.1016/j.giec.2014.09.005.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyAdverse eventsRetrograde cholangiopancreatographyERCP-related adverse eventsProcedure-related risk factorsOverall adverse event rateAdverse event ratesManagement of patientsPost-ERCP pancreatitisRoutine endoscopic proceduresRisk factorsPancreaticobiliary diseasesEndoscopic proceduresEvent ratesCholangiopancreatographyMonumental advancesInherent risksHigher inherent riskBleedingPancreatitisSedationPatientsInfectionDiseaseDiagnosis
2014
Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features
Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Disease-a-Month 2014, 60: 530-550. PMID: 25510320, DOI: 10.1016/j.disamonth.2014.11.002.Peer-Reviewed Original Research
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence
1993
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients
Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, Hawes R, Lehman G. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointestinal Endoscopy 1993, 39: 652-657. PMID: 8224687, DOI: 10.1016/s0016-5107(93)70217-5.Peer-Reviewed Original ResearchConceptsHigh-risk patientsMain pancreatic ductSmaller common bile duct diameterCommon bile duct diameterBile duct diameterStent groupEndoscopic sphincterotomyPancreatic ductDuct diameterIncidence of pancreatitisIndependent risk factorPre-cut sphincterotomyOddi dysfunctionProphylactic stentingHospital daysCommon complicationPapillary edemaSevere pancreatitisBiliary sphincterotomyStent placementRisk factorsProspective fashionSphincterotomyPancreatitisPatients